Atlas Trials

Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)

Clinical trial NCT03540160 · TERMINATED

Trial details

NCT number
NCT03540160
Sponsor
Vyne Therapeutics Inc.
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
PruritusPrurigo NodularisAtopic DermatitisPsoriasis
Start date
2018-03-15
Primary completion
2020-04-08
Enrollment
558

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.